These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 35122754

  • 1. The anti-MDR efficacy of YAN against A549/Taxol cells is associated with its inhibition on glycolysis and is further enhanced by 2-deoxy-d-glucose.
    Gao M, Yang Y, Gao Y, Liu T, Guan Q, Zhou T, Shi Y, Hao M, Li Z, Zuo D, Zhang W, Wu Y.
    Chem Biol Interact; 2022 Feb 25; 354():109843. PubMed ID: 35122754
    [Abstract] [Full Text] [Related]

  • 2. YAN, a novel microtubule inhibitor, inhibits P-gp and MRP1 function and induces mitotic slippage followed by apoptosis in multidrug-resistant A549/Taxol cells.
    Gao M, Liu T, Li J, Guan Q, Wang H, Yan S, Li Z, Zuo D, Zhang W, Wu Y.
    Toxicol In Vitro; 2020 Dec 25; 69():104971. PubMed ID: 32805372
    [Abstract] [Full Text] [Related]

  • 3. Targeting the ROS/PI3K/AKT/HIF-1α/HK2 axis of breast cancer cells: Combined administration of Polydatin and 2-Deoxy-d-glucose.
    Zhang T, Zhu X, Wu H, Jiang K, Zhao G, Shaukat A, Deng G, Qiu C.
    J Cell Mol Med; 2019 May 25; 23(5):3711-3723. PubMed ID: 30920152
    [Abstract] [Full Text] [Related]

  • 4. Wogonin reverses hypoxia resistance of human colon cancer HCT116 cells via downregulation of HIF-1α and glycolysis, by inhibiting PI3K/Akt signaling pathway.
    Wang H, Zhao L, Zhu LT, Wang Y, Pan D, Yao J, You QD, Guo QL.
    Mol Carcinog; 2014 Feb 25; 53 Suppl 1():E107-18. PubMed ID: 23761018
    [Abstract] [Full Text] [Related]

  • 5. BZML, a novel colchicine binding site inhibitor, overcomes multidrug resistance in A549/Taxol cells by inhibiting P-gp function and inducing mitotic catastrophe.
    Bai Z, Gao M, Zhang H, Guan Q, Xu J, Li Y, Qi H, Li Z, Zuo D, Zhang W, Wu Y.
    Cancer Lett; 2017 Aug 28; 402():81-92. PubMed ID: 28576750
    [Abstract] [Full Text] [Related]

  • 6. Overcoming resistance to mitochondrial apoptosis by BZML-induced mitotic catastrophe is enhanced by inhibition of autophagy in A549/Taxol cells.
    Bai Z, Gao M, Xu X, Zhang H, Xu J, Guan Q, Wang Q, Du J, Li Z, Zuo D, Zhang W, Wu Y.
    Cell Prolif; 2018 Aug 28; 51(4):e12450. PubMed ID: 29493085
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of Aerobic Glycolysis Represses Akt/mTOR/HIF-1α Axis and Restores Tamoxifen Sensitivity in Antiestrogen-Resistant Breast Cancer Cells.
    Woo YM, Shin Y, Lee EJ, Lee S, Jeong SH, Kong HK, Park EY, Kim HK, Han J, Chang M, Park JH.
    PLoS One; 2015 Aug 28; 10(7):e0132285. PubMed ID: 26158266
    [Abstract] [Full Text] [Related]

  • 8. Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin.
    Lin H, Hu B, He X, Mao J, Wang Y, Wang J, Zhang T, Zheng J, Peng Y, Zhang F.
    Biochem Pharmacol; 2020 Jan 28; 171():113733. PubMed ID: 31783010
    [Abstract] [Full Text] [Related]

  • 9. Knockdown of KLF5 suppresses hypoxia-induced resistance to cisplatin in NSCLC cells by regulating HIF-1α-dependent glycolysis through inactivation of the PI3K/Akt/mTOR pathway.
    Gong T, Cui L, Wang H, Wang H, Han N.
    J Transl Med; 2018 Jun 14; 16(1):164. PubMed ID: 29898734
    [Abstract] [Full Text] [Related]

  • 10. Targeting aerobic glycolysis and HIF-1alpha expression enhance imiquimod-induced apoptosis in cancer cells.
    Huang SW, Kao JK, Wu CY, Wang ST, Lee HC, Liang SM, Chen YJ, Shieh JJ.
    Oncotarget; 2014 Mar 15; 5(5):1363-81. PubMed ID: 24658058
    [Abstract] [Full Text] [Related]

  • 11. Hypoxia-inducible transcription factor-1alpha promotes hypoxia-induced A549 apoptosis via a mechanism that involves the glycolysis pathway.
    Luo F, Liu X, Yan N, Li S, Cao G, Cheng Q, Xia Q, Wang H.
    BMC Cancer; 2006 Jan 27; 6():26. PubMed ID: 16438736
    [Abstract] [Full Text] [Related]

  • 12. Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose.
    Maher JC, Wangpaichitr M, Savaraj N, Kurtoglu M, Lampidis TJ.
    Mol Cancer Ther; 2007 Feb 27; 6(2):732-41. PubMed ID: 17308069
    [Abstract] [Full Text] [Related]

  • 13. A multiple-targets alkaloid nuciferine overcomes paclitaxel-induced drug resistance in vitro and in vivo.
    Liu RM, Xu P, Chen Q, Feng SL, Xie Y.
    Phytomedicine; 2020 Dec 27; 79():153342. PubMed ID: 32992085
    [Abstract] [Full Text] [Related]

  • 14. Timosaponin AIII, a steroidal saponin, exhibits anti-tumor effect on taxol-resistant cells in vitro and in vivo.
    Song XY, Han FY, Chen JJ, Wang W, Zhang Y, Yao GD, Song SJ.
    Steroids; 2019 Jun 27; 146():57-64. PubMed ID: 30951756
    [Abstract] [Full Text] [Related]

  • 15. Jiedu Sangen decoction inhibits chemoresistance to 5-fluorouracil of colorectal cancer cells by suppressing glycolysis via PI3K/AKT/HIF-1α signaling pathway.
    Sun LT, Zhang LY, Shan FY, Shen MH, Ruan SM.
    Chin J Nat Med; 2021 Feb 27; 19(2):143-152. PubMed ID: 33641785
    [Abstract] [Full Text] [Related]

  • 16. Salvianolic acid B inhibits glycolysis in oral squamous cell carcinoma via targeting PI3K/AKT/HIF-1α signaling pathway.
    Wei J, Wu J, Xu W, Nie H, Zhou R, Wang R, Liu Y, Tang G, Wu J.
    Cell Death Dis; 2018 May 22; 9(6):599. PubMed ID: 29789538
    [Abstract] [Full Text] [Related]

  • 17. Autophagy inhibition with chloroquine reverts paclitaxel resistance and attenuates metastatic potential in human nonsmall lung adenocarcinoma A549 cells via ROS mediated modulation of β-catenin pathway.
    Datta S, Choudhury D, Das A, Mukherjee DD, Dasgupta M, Bandopadhyay S, Chakrabarti G.
    Apoptosis; 2019 Jun 22; 24(5-6):414-433. PubMed ID: 30767087
    [Abstract] [Full Text] [Related]

  • 18. Apatinib Reverses Paclitaxel-resistant Lung Cancer Cells (A549) Through Blocking the Function of ABCB1 Transporter.
    Zhang Q, Song Y, Cheng X, Xu Z, Matthew OA, Wang J, Sun Z, Zhang X.
    Anticancer Res; 2019 Oct 22; 39(10):5461-5471. PubMed ID: 31570440
    [Abstract] [Full Text] [Related]

  • 19. Suppression of MAPK Signaling and Reversal of mTOR-Dependent MDR1-Associated Multidrug Resistance by 21α-Methylmelianodiol in Lung Cancer Cells.
    Aldonza MB, Hong JY, Bae SY, Song J, Kim WK, Oh J, Shin Y, Lee SH, Lee SK.
    PLoS One; 2015 Oct 22; 10(6):e0127841. PubMed ID: 26098947
    [Abstract] [Full Text] [Related]

  • 20. NOX4 supports glycolysis and promotes glutamine metabolism in non-small cell lung cancer cells.
    Zeng C, Wu Q, Wang J, Yao B, Ma L, Yang Z, Li J, Liu B.
    Free Radic Biol Med; 2016 Dec 22; 101():236-248. PubMed ID: 27989748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.